F259-0693 Screening compound: N-(2-acetamido-4-methoxy-1,3-benzothiazol-6-yl)-4-(6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl)butanamide

F259-0693 Screening compound: N-(2-acetamido-4-methoxy-1,3-benzothiazol-6-yl)-4-(6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl)butanamide
F259-0693 Screening compound: N-(2-acetamido-4-methoxy-1,3-benzothiazol-6-yl)-4-(6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl)butanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F259-0693
N-(2-acetamido-4-methoxy-1,3-benzothiazol-6-yl)-4-(6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl)butanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F259-0693

Molecular Formula

C23H24N4O5S (C23 H24 N4 O5 S)

Compound Name

N-(2-acetamido-4-methoxy-1,3-benzothiazol-6-yl)-4-(6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl)butanamide

IUPAC name

N-(2-acetamido-4-methoxy-13-benzothiazol-6-yl)-4-(6-methyl-3-oxo-34-dihydro-2H-14-benzoxazin-4-yl)butanamide

SMILES

CC(Nc1nc(c(OC)cc(NC(CCCN2c(cc(C)cc3)c3OCC2=O)=O)c2)c2s1)=O

InChI

InChI=1S/C23H24N4O5S/c1-13-6-7-17-16(9-13)27(21(30)12-32-17)8-4-5-20(29)25-15-10-18(31-3)22-19(11-15)33-23(26-22)24-14(2)28/h6-7,9-11H,4-5,8,12H2,1-3H3,(H,25,29)(H,24,26,28)

InChI Key

TVDQZZSVIWMVTI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14946623

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

468.53

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.318

Distribution Coefficient, logD

2.318

Water Solubility, LogSw

-2.95

Polar Surface Area

88.620

Acid Dissociation Constant (pKa)

10.39

Base Dissociation Constant (pKb)

0.96

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.40

F259-0693 in Drug Discovery

Included in Screening Libraries

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F259-0693 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F259-0693?
Check Price and Availability of F259-0693, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F259-0693 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F259-0693
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F259-0693
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F259-0693 available by request